| Name: | R-Tech Ueno, Ltd. |
| Established: | September 1989 |
| Head Office: | NBF Hibiya Bldg., 10F, 1-1-7 Uchisaiwaicho, Chiyoda-ku, Tokyo 100-0011, Japan Tel: +81-3-3596-8011 Fax: +81-3-3596-8023  |
| Sanda Office: | 4-1 Techno-Park, Sanda, Hyogo 669-1339, Japan Tel: +81-79-560-7181 Fax: +81-79-560-7180 |
| Capital: | 653,987,000 yen |
| Number of Employees: | 73 (As of March 31, 2010) |
| Representative: | Yukihiko Mashima (President) |
| Business: | Research and development, manufacture, sales, Development Assistance and Contract Manufacturing Services of pharmaceutical products |
| Laboratories and Plants: | 4-1 Techno-Park, Sanda, Hyogo 669-1339, Japan |
| Board Director: | Yukihiko Mashima (President) Tadashi Hayashi (Managing Director) Sachiko Kuno Shinya Homma |
| Corporate Auditor: | Motoyuki Sakasegawa Eiji Asada Kazuyuki Taguchi |
| Audit Corporation: | Deloitte Touche Tohmatsu LLC |
September, 1989 |
Established for manufacturing, marketing and R & D of pharmaceuticals as major business objectives. |
April, 2001 |
Marketing and manufacturing operations for Rescula® Eye Drops was inherited from Ueno Fine Chemicals Industry，Ltd． |
April, 2003 |
Employees were transferred from Prescription Drug Division, Ueno Fine Chemicals Industry，Ltd． |
June, 2003 |
Pharma Chemical Division and Prescription Drug Division were established. |
September 2004 |
Headquarters moved to Chiyoda-ku, Tokyo |
October, 2004 |
Marketing affiliation for Rescula® Eye Drops was changed from Fujisawa Pharmaceutical Co., Ltd (actual Astellas Pharma Inc.) to Santen Pharmaceutical Co., Ltd. Contract for manufacturing and provision of Amitiza® capsule was made with Takeda Pharmaceutical Company Limited and Sucampo Pharmaceuticals, Inc. |
April, 2005 |
Translational Research Promotion Division was established. |
September, 2005 |
Sanda Office obtained approval for a factory manufacturing Amitiza® drug substance from U.S. Food and Drug Administration (FDA). |
September, 2006 |
Science group was established in Pharmaceutical Division for reinforcing domestic marketing of Rescula ® Eye Drops. |
April, 2008 |
Listed on Hercules, Osaka Securities Exchange. |
October, 2008 |
Sanda office obtained approval for a factory manufacturing Amitiza® drug substance from Medicines and Healthcare Products Regulatory Agency (MHRA), UK. |
February, 2009 |
Contract for exclusive manufacturing and provision of Amitiza® capsule to Japan, Asia and Oceania Areas was made. |
April, 2009 |
Contract for assignment of marketing approval and dealership of Rescula® Eye Drops, licensing of related patents, and exclusive manufacturing and provision of the product in U.S. and Canada for indications of glaucoma and ocular hypertension was made with Sucampo Pharma Americas, Inc. |
August, 2009 |
Ophthalmology and Dermatology Division and Medical Advisory Bord were established. |
May, 2010 |
Sanda Office obtained approval for a factory manufacturing Rescula® Eye Drops from U.S. Food and Drug Administration (FDA). |
As of March 31, 2010
▼ The 10 Members of the R-Tech Ueno Medical Advisory Board |
|
| Glaucoma: | Dr. Kazuhisa Sugiyama Professor, Department of Ophthalmology & Visual Science, Graduate School of Medical Science, Kanazawa University |
| Dr. Goji Tomita Professor, 2nd Department of Ophthalmology, School of Medicine, Faculty of Medicine, Toho University |
|
| Vitreoretinal disease: | Dr. Yozo Miyake (Chairman) Professor Emeritus, Department of Ophthalmology, Graduate School of Medicine, Nagoya University |
| Dr. Akito Hirakata Professor, Department of Ophthalmology, Faculty of Medicine, Kyorin University |
|
| Dr. Taiji Sakamoto Professor, Department of Ophthalmology, Faculty of Medicine, Kagoshima University |
|
| Cataracts: | Dr. Daijiro Kurosaka Professor, Department of Ophthalmology, Faculty of Medicine, Iwate Medical University |
| Keratoconjunctivitis: | Dr. Teruo Nishida Professor, Department of Ophthalmology, Graduate School of Medicine, Yamaguchi University |
| Neuro-ophthalmology: | Dr. Yoshihisa Oguchi Professor Emeritus, Department of Ophthalmology, School of Medicine, Keio University |
| Ophthalmologists: | Dr. Hidenao Ideta Director Emeritus, Ideta Eye Hospital |
| Dr. Kenji Inoue President, Inoue Eye Hospital |
|
